These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 25512797)

  • 61. The Immune Landscape in Nonalcoholic Steatohepatitis.
    Narayanan S; Surette FA; Hahn YS
    Immune Netw; 2016 Jun; 16(3):147-58. PubMed ID: 27340383
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A Young Adult Patient with Nonalcoholic Steatohepatitis Developed Severe Gastroesophageal Varices Associated with Severe Obesity and Diabetes Mellitus.
    Honma Y; Sumida K; Ogino N; Kusanaga M; Minami S; Kumei S; Matsuoka H; Watanabe T; Hiura M; Abe S; Shibata M; Harada M
    Case Rep Gastroenterol; 2018; 12(2):487-496. PubMed ID: 30283282
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Recent advances in mouse models of obesity- and nonalcoholic steatohepatitis-associated hepatocarcinogenesis.
    Nakagawa H
    World J Hepatol; 2015 Aug; 7(17):2110-8. PubMed ID: 26301053
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A juvenile case with nonalcoholic steatohepatitis and traditional Korean medicine-based treatment.
    Son CG
    Integr Med Res; 2018 Jun; 7(2):206-209. PubMed ID: 29989032
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Development of nonalcoholic steatohepatitis model through combination of high-fat diet and tetracycline with morbid obesity in mice.
    Ito M; Suzuki J; Sasaki M; Watanabe K; Tsujioka S; Takahashi Y; Gomori A; Hirose H; Ishihara A; Iwaasa H; Kanatani A
    Hepatol Res; 2006 Feb; 34(2):92-8. PubMed ID: 16423558
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Fatty liver in childhood.
    Ozturk Y; Soylu OB
    World J Hepatol; 2014 Jan; 6(1):33-40. PubMed ID: 24653792
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Is there a role for adaptive immunity in nonalcoholic steatohepatitis?
    Sutti S; Jindal A; Bruzzì S; Locatelli I; Bozzola C; Albano E
    World J Hepatol; 2015 Jul; 7(13):1725-9. PubMed ID: 26167244
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Development of Fibrosis in Nonalcoholic Steatosis through Combination of a Synthetic Diet Rich in Disaccharide and Low-Dose Lipopolysaccharides in the Livers of Zucker (fa/fa) Rats.
    Fukunishi S; Nishio H; Fukuda A; Takeshita A; Hanafusa T; Higuchi K; Suzuki K
    J Clin Biochem Nutr; 2009 Nov; 45(3):322-8. PubMed ID: 19902023
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Pharmacologic Management of Nonalcoholic Steatohepatitis.
    Neuschwander-Tetri BA
    Gastroenterol Hepatol (N Y); 2018 Oct; 14(10):582-589. PubMed ID: 30846912
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Intrauterine growth retardation and nonalcoholic Fatty liver disease in children.
    Alisi A; Panera N; Agostoni C; Nobili V
    Int J Endocrinol; 2011; 2011():269853. PubMed ID: 22190925
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Triantennary GalNAc Molecular Imaging Probes for Monitoring Hepatocyte Function in a Rat Model of Nonalcoholic Steatohepatitis.
    Mishra A; Castañeda TR; Bader E; Elshorst B; Cummings S; Scherer P; Bangari DS; Loewe C; Schreuder H; Pöverlein C; Helms M; Jones S; Zech G; Licher T; Wagner M; Schudok M; de Hoop M; Plowright AT; Atzrodt J; Kannt A; Laitinen I; Derdau V
    Adv Sci (Weinh); 2020 Dec; 7(24):2002997. PubMed ID: 33344141
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Fatty liver disease in children: eat now pay later.
    De Bruyne RM; Fitzpatrick E; Dhawan A
    Hepatol Int; 2010 Jan; 4(1):375-85. PubMed ID: 20305757
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Assessment of Classification Models and Relevant Features on Nonalcoholic Steatohepatitis Using Random Forest.
    García-Carretero R; Holgado-Cuadrado R; Barquero-Pérez Ó
    Entropy (Basel); 2021 Jun; 23(6):. PubMed ID: 34204225
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Glitazones for human nonalcoholic steatohepatitis.
    Pais R; Moraru I; Ratziu V
    Therap Adv Gastroenterol; 2011 Sep; 4(5):325-34. PubMed ID: 21922031
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Alleviation of insulin resistance and liver damage by oral administration of Imm124-E is mediated by increased Tregs and associated with increased serum GLP-1 and adiponectin: results of a phase I/II clinical trial in NASH.
    Mizrahi M; Shabat Y; Ben Ya'acov A; Lalazar G; Adar T; Wong V; Muller B; Rawlin G; Ilan Y
    J Inflamm Res; 2012; 5():141-50. PubMed ID: 23293533
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Need for liver biopsy in pediatric nonalcoholic steatohepatitis diagnosis regardless of improvement in liver damage through weight loss.
    Kakiuchi T; Koji A; Yoshiura M
    Clin Case Rep; 2022 Mar; 10(3):e05652. PubMed ID: 35356164
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The Diabetes Syndrome - A Collection of Conditions with Common, Interrelated Pathophysiologic Mechanisms.
    Rachfal AW; Grant SFA; Schwartz SS
    Int J Gen Med; 2021; 14():923-936. PubMed ID: 33776471
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Nonalcoholic steatohepatitis in Asia-Oceania.
    Saibara T
    Hepatol Res; 2005 Oct; 33(2):64-7. PubMed ID: 16256425
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The multi-hit process and the antagonistic roles of tumor necrosis factor-alpha and adiponectin in non alcoholic fatty liver disease.
    Polyzos SA; Kountouras J; Zavos Ch
    Hippokratia; 2009 Apr; 13(2):127; author reply 128. PubMed ID: 19561788
    [No Abstract]   [Full Text] [Related]  

  • 80. Topological and functional analysis of nonalcoholic steatohepatitis through protein interaction mapping.
    Asadzadeh-Aghdaee H; Mansouri V; Peyvandi AA; Moztarzadeh F; Okhovatian F; Lahmi F; Vafaee R; Zali MR
    Gastroenterol Hepatol Bed Bench; 2016 Dec; 9(Suppl1):S23-S28. PubMed ID: 28224024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.